320 related articles for article (PubMed ID: 15681418)
1. Inhibition of coxsackievirus B3 replication by small interfering RNAs requires perfect sequence match in the central region of the viral positive strand.
Yuan J; Cheung PK; Zhang HM; Chau D; Yang D
J Virol; 2005 Feb; 79(4):2151-9. PubMed ID: 15681418
[TBL] [Abstract][Full Text] [Related]
2. Expression of short hairpin RNAs against the coxsackievirus B3 exerts potential antiviral effects in Cos-7 cells and in mice.
Kim JY; Chung SK; Hwang HY; Kim H; Kim JH; Nam JH; Park SI
Virus Res; 2007 Apr; 125(1):9-13. PubMed ID: 17222937
[TBL] [Abstract][Full Text] [Related]
3. Developing an effective RNA interference strategy against a plus-strand RNA virus: silencing of coxsackievirus B3 and its cognate coxsackievirus-adenovirus receptor.
Werk D; Schubert S; Lindig V; Grunert HP; Zeichhardt H; Erdmann VA; Kurreck J
Biol Chem; 2005 Sep; 386(9):857-63. PubMed ID: 16164410
[TBL] [Abstract][Full Text] [Related]
4. [Short interfering RNA-mediated inhibition of coxsakievirus B3 infection in vitro].
Han JS; Xiao ZH; Yao HL; Ren HY; Liu ZW
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):150-2. PubMed ID: 17653320
[TBL] [Abstract][Full Text] [Related]
5. [Intracellular clearance of Coxsakievirus B3 infection by short interfering RNA and its mechanism study].
Xiao ZH; Han JS; Yao HL; Liu ZW
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):260-2. PubMed ID: 19105337
[TBL] [Abstract][Full Text] [Related]
6. Targeting 2A protease by RNA interference attenuates coxsackieviral cytopathogenicity and promotes survival in highly susceptible mice.
Merl S; Michaelis C; Jaschke B; Vorpahl M; Seidl S; Wessely R
Circulation; 2005 Apr; 111(13):1583-92. PubMed ID: 15795330
[TBL] [Abstract][Full Text] [Related]
7. Targeting of protease 2A genome by single and multiple siRNAs as a strategy to impair CVB3 life cycle in permissive HeLa cells.
Racchi G; Klingel K; Kandolf R; Grassi G
Methods Find Exp Clin Pharmacol; 2009 Mar; 31(2):63-70. PubMed ID: 19455260
[TBL] [Abstract][Full Text] [Related]
8. [Inhibitory effect of CVB3-VP1 siRNA on CVB3 replication].
Chen JB; Xu CF; Yu Y; Li L; Li SJ; Chen RZ; Yang YZ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 May; 22(3):306-9. PubMed ID: 16643786
[TBL] [Abstract][Full Text] [Related]
9. Development of potential antiviral strategy against coxsackievirus B4.
Tan EL; Wong AP; Poh CL
Virus Res; 2010 Jun; 150(1-2):85-92. PubMed ID: 20214933
[TBL] [Abstract][Full Text] [Related]
10. Strand-specific silencing of a picornavirus by RNA interference: evidence for the superiority of plus-strand specific siRNAs.
Schubert S; Rothe D; Werk D; Grunert HP; Zeichhardt H; Erdmann VA; Kurreck J
Antiviral Res; 2007 Mar; 73(3):197-205. PubMed ID: 17112603
[TBL] [Abstract][Full Text] [Related]
11. Small interfering RNA against the 2C genomic region of coxsackievirus B3 exerts potential antiviral effects in permissive HeLa cells.
Luan Y; Dai HL; Yang D; Zhu L; Gao TL; Shao HJ; Peng X; Jin ZF
Virus Res; 2012 Jan; 163(1):183-9. PubMed ID: 21945637
[TBL] [Abstract][Full Text] [Related]
12. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of coxsackievirus B3 in cell cultures and in mice by peptide-conjugated morpholino oligomers targeting the internal ribosome entry site.
Yuan J; Stein DA; Lim T; Qiu D; Coughlin S; Liu Z; Wang Y; Blouch R; Moulton HM; Iversen PL; Yang D
J Virol; 2006 Dec; 80(23):11510-9. PubMed ID: 16987987
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
Zhou L; He X; Gao B; Xiong S
J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
[TBL] [Abstract][Full Text] [Related]
15. A small interfering RNA targeting coxsackievirus B3 protects permissive HeLa cells from viral challenge.
Ahn J; Jun ES; Lee HS; Yoon SY; Kim D; Joo CH; Kim YK; Lee H
J Virol; 2005 Jul; 79(13):8620-4. PubMed ID: 15956603
[TBL] [Abstract][Full Text] [Related]
16. A phosphorothioate antisense oligodeoxynucleotide specifically inhibits coxsackievirus B3 replication in cardiomyocytes and mouse hearts.
Yuan J; Cheung PK; Zhang H; Chau D; Yanagawa B; Cheung C; Luo H; Wang Y; Suarez A; McManus BM; Yang D
Lab Invest; 2004 Jun; 84(6):703-14. PubMed ID: 15094712
[TBL] [Abstract][Full Text] [Related]
17. Maintaining inhibition: siRNA double expression vectors against coxsackieviral RNAs.
Schubert S; Grunert HP; Zeichhardt H; Werk D; Erdmann VA; Kurreck J
J Mol Biol; 2005 Feb; 346(2):457-65. PubMed ID: 15670596
[TBL] [Abstract][Full Text] [Related]
18. [Inhibition of virus infection in coxsackievirus-induced myocarditis model by RNA interference].
Yao HL; He F; Xiao ZH; Liu ZW
Bing Du Xue Bao; 2012 Sep; 28(5):527-30. PubMed ID: 23233928
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of fatty acid synthase by amentoflavone reduces coxsackievirus B3 replication.
Wilsky S; Sobotta K; Wiesener N; Pilas J; Althof N; Munder T; Wutzler P; Henke A
Arch Virol; 2012 Feb; 157(2):259-69. PubMed ID: 22075919
[TBL] [Abstract][Full Text] [Related]
20.
Lee YG; Park JH; Jeon ES; Kim JH; Lim BK
J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
